| Germany |
Population study of TB in Hamburg |
673 |
2008–2017 |
Enriched for pulmonary TB due to ease of sampling |
| UK |
Population study of TB in Birmingham |
1653 |
2009–2019 |
|
| Italy |
All pulmonary TB isolates from patients in Milan |
90 |
2018–2019 |
Pulmonary TB only |
| South Africa |
Bedaquiline resistance prevalence study among patients with MDR-TB |
175 |
2015–2019 |
Enriched for rifampicin resistant; pulmonary TB only |
| Vietnam 1 |
Observational studies of all pulmonary TB |
1536 |
2008–2011 |
Pulmonary TB only |
| Vietnam 2 |
Observational study of MDR pulmonary TB |
257 |
2017–2020 |
Pulmonary MDR-TB only |
| Vietnam 3 |
Observational study of rifampicin susceptible pulmonary TB |
537 |
2017–2020 |
Pulmonary Rifampicin-susceptible TB only |
| Vietnam 4 |
Clinical trial of TB meningitis |
370 |
2011–2014 |
TB meningitis only |
| Vietnam 5 |
Clinical trial of TB meningitis in HIV infected individuals |
111 |
2017–2020 |
TB meningitis only; HIV+ |
| Vietnam 6 |
Clinical trial of TB meningitis in HIV uninfected individuals |
105 |
2018–2020 |
TB meningitis only; HIV- |
| Indonesia 1 |
Clinical trial of TB meningitis |
106 |
2006–2016 |
TB meningitis only |
| Indonesia 2 |
Observational study of pulmonary TB, enriched for MDR-TB |
765 |
2006–2016 |
Pulmonary TB only; enriched for MDR-TB |
| China |
Population prevalence study of pulmonary TB |
5445 |
2013–2017 |
Pulmonary TB only |
| Peru |
Observational study of pulmonary TB |
429 |
2018–2019 |
Pulmonary TB only |
